Should You Sell Acer Therapeutics Inc (ACER) in Biotechnology Industry?

Tuesday, November 07, 2023 12:55 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Sell Acer Therapeutics Inc (ACER) in Biotechnology Industry?

A rating of 93 puts Acer Therapeutics Inc (ACER) near the top of the Biotechnology industry according to InvestorsObserver. Acer Therapeutics Inc's score of 93 means it scores higher than 93% of stocks in the industry. Acer Therapeutics Inc also received an overall rating of 76, putting it above 76% of all stocks. Biotechnology is ranked 46 out of the 148 industries.

ACER has an Overall Score of 76. Find out what this means to you and get the rest of the rankings on ACER!

See Full ACER Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Acer Therapeutics Inc Stock Today?

Acer Therapeutics Inc (ACER) stock is unmoved -0.36% while the S&P 500 is up 0.19% as of 12:54 PM on Tuesday, Nov 7. ACER is unchanged $0.00 from the previous closing price of $0.85 on volume of 19,556 shares. Over the past year the S&P 500 is higher by 14.91% while ACER has fallen -35.11%. ACER lost -$1.95 per share the over the last 12 months. Click Here to get the full Stock Report for Acer Therapeutics Inc stock.